August 10, 2023
Dr. Chris Lewis first visited Tanzania nearly 20 years ago as a UC medical resident intent on making a difference in the country. Now he’s instilling a passion for global health in a new generation of students through Village Life Outreach Project.
July 25, 2023
A team of UC students, faculty, staff and supporters traveled to East Africa for a service-learning trip across three villages in Tanzania. They returned to campus with a transformational cultural experience and lessons that last a lifetime.
December 15, 2023
Review the University of Cincinnati's historic and productive year in 2023 through our year-in-review website.
October 6, 2022
Researchers at the University of Cincinnati are leading the CAPSTONE study that will learn more about how inflammation affects patient recovery after intracerebral hemorrhage strokes.
June 5, 2023
University of Cincinnati researchers have enrolled the first four patients in a first-of-its-kind trial that will test a treatment for abnormal brain activity sometimes referred to as a “brain tsunami.”
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
June 30, 2023
A monthslong shortage of chemotherapies forces some patients to receive less treatment. University of Cincinnati Cancer Center's Davendra Sohal told the Wall Street Journal his patients were also impacted.
April 11, 2023
The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.
April 13, 2023
The University of Cincinnati is enrolling patients in an Imvax study that will test the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.